The Avisa BreathTest is the world’s first point of care biomarker system that analyzes exhaled breath to detect & monitor pulmonary infection.
It is the world’s first breath test to detect & monitor pulmonary infections and is the only test that can differentiate a virulent bacterial infection from strep pneumonia and viral lung infection.
A biomarker point-of-care test for rapidly detecting pulmonary infections. The Avisa BreathTest is a biomarker, quantitative, point-of-care test for rapidly detecting pulmonary infections due to certain virulent pathogens without the need to collect and culture sputum or other biological samples.
Please visit the company’s news section of their website for their latest news https://www.avisapharma.com/news/
P: 505-820-1400 x11 | 484-459-5076 cell
E: [email protected]